Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Rheumatology International|August 23, 2019
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohortEnnio G Favalli, Andrea Becciolini, Antonio Carletto, et al.Journal of Clinical Medicine|March 14, 2026
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study GroupAlessandra Bezzi, Federica Lumetti, Martina Orlandi, et al.Rheumatology (Oxford, England)|December 13, 2023
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation studyAlberto Floris, Riccardo Laconi, Gerard Espinosa, et al.Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.Clinical Hemorheology and Microcirculation|January 28, 2014
Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parametersAndreina Manfredi, Marco Sebastiani, Valeria Carraro, et al.Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.Acta Bio-Medica : Atenei Parmensis|August 4, 2023
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literatureLuca Magnani, Alarico Ariani, Andrea Lo Monaco, et al.Reumatismo|November 17, 2025
The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung diseaseChiara Crotti, Nicola Ughi, Carlo Alberto Scirè, et al.Pageof 4